<DOC>
	<DOCNO>NCT02127788</DOCNO>
	<brief_summary>The purpose observational study describe actual condition prescription micafungin antifungal prophylaxis French haematological onco-haematological unit . The efficacy safety outcomes describe .</brief_summary>
	<brief_title>Use Micafungin ( MycamineÂ® ) Antifungal Prophylaxis Haematology Onco-haematology</brief_title>
	<detailed_description />
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Adult patient haemopathy paediatric patient haemopathy solid tumor . Patient hospitalize haematology , oncohaematology oncopaediatrics unit . Patient initiate antifungal prophylaxis micafungin . Patient present documented fungal infection . Patient already include biomedical study impact care management invasive fungal infection time inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Haematology</keyword>
	<keyword>Micafungin</keyword>
	<keyword>Observational study</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Invasive Fungal Infection</keyword>
	<keyword>France</keyword>
</DOC>